These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29155052)

  • 21. Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.
    May-Zhang LS; Yermalitsky V; Melchior JT; Morris J; Tallman KA; Borja MS; Pleasent T; Amarnath V; Song W; Yancey PG; Davidson WS; Linton MF; Davies SS
    J Biol Chem; 2019 Dec; 294(50):19022-19033. PubMed ID: 31666337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
    Nicholls SJ; Zheng L; Hazen SL
    Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
    Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
    Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein.
    Zhang X; Wang J; Chen B
    Biochem Biophys Res Commun; 2010 Oct; 401(3):473-9. PubMed ID: 20869952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
    Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
    Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology.
    Koschinsky ML; Boffa MB
    Atherosclerosis; 2022 May; 349():92-100. PubMed ID: 35606081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ApoA-II versus ApoA-I: two for one is not always a good deal.
    Castellani LW; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1870-2. PubMed ID: 11742857
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of myeloperoxidase oxidation and
    Kameda T; Horiuchi Y; Shimano S; Yano K; Lai SJ; Ichimura N; Tohda S; Kurihara Y; Tozuka M; Ohkawa R
    Biol Chem; 2022 Feb; 403(3):265-277. PubMed ID: 34448387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
    Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
    Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Suvarnakar UV; Pande AH
    Biochim Biophys Acta; 2012 Sep; 1821(9):1200-10. PubMed ID: 22634518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
    Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
    J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic inflammation, intestine, and paraoxonase-1.
    Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
    Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein.
    Ito F; Ito T; Suzuki C; Yahata T; Ikeda K; Hamaoka K
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
    Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
    J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.